Scholarly Index
Lipika Goyal
Stanford Medicine; 18,008 total citations; 324 total publications; best world rank #6
Stanford Medicine
18,008Total citations
324Total publications
57H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 217 | US 78 | 98.95 |
| Fibroblast Growth Factor Research | Lifetime | 126 | US 67 | 97.54 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 856 | US 366 | 98.19 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 861 | US 225 | 97.57 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 401 | US 92 | 89.56 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 20 | US 6 | 99.51 |
| Fibroblast Growth Factor Research | 2021-2025 | 6 | US 4 | 99.11 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 128 | US 44 | 98.62 |
| Cancer Diagnosis and Treatment | 2021-2025 | 244 | US 59 | 87.66 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 47 | US 7 | 92.05 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 996 | US 170 | 90.91 |
| Peptidase Inhibition and Analysis | 2021-2025 | 807 | US 194 | 87.66 |
| Viral-associated cancers and disorders | 2021-2025 | 662 | US 243 | 82.87 |
| Soft tissue tumor case studies | 2021-2025 | 257 | US 92 | 73.05 |
| Kruppel-like factors research | 2021-2025 | 456 | US 100 | 64.12 |